eli lilly and company news - Search News

Eli Lilly investing $4.5 billion more into LEAP district

YAHOO!Finance · 3h

Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant

The Medicine Foundry, which is expected to create 400 jobs, will be situated in the LEAP Research and Innovation District in Lebanon, Indiana. Lilly has already made significant investments in Lebanon,

Indianapolis Star on MSN · 12h

Eli Lilly plans $4.5 billion facility in LEAP District, bringing investment to $13 billion

The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing under one roof.

Purdue Exponent · 1d

Eli Lilly and Company invests additional $4.5 billion to LEAP

Eli Lilly and Company announced an increased budget for the LEAP by $4.5 billion. The increased budget goes toward the Lilly Medicine Foundry in the proposed LEAP district.

Eli Lilly, food and drug administration

Hosted on MSN · 6h

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.

Barron's on MSN · 9h

Eli Lilly’s Weight-Loss Drugs Are No Longer in Short Supply. That’s Bad for Hims & Hers.

Blockbuster drugs Zepbound and Mounjaro have come off the FDA's shortage list. Shares of Hims & Hers, which had capitalized on the pinch, are tumbling.

FiercePharma · 9h

Eli Lilly's shortage of diabetes and obesity drugs is over, halting competition with knock-offs

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, freeing the company from competing with compounding pharmacies that have been producing copycat versions of the in-demand treatments.

1d

Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements

Lilly will add the center to a site in Lebanon, Indiana, where it is already spending about $9 billion to improve ...

9h

Eli Lilly & Co (LLY) Gets a Buy from Truist Financial

In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Eli Lilly & Co (LLY – Research ...

High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project

As Eli Lilly has surged to become the most valuable company in biopharma—with a market cap now more than twice that of ...

14h

Eli Lilly, Moderna and more: The 5 highest paid healthcare CEOs

Health care stocks underperformed the broader market in 2023, with many companies falling short of their profit targets, and ...

3don MSN

Eli Lilly and Company (LLY) Gets Strong Buy Rating Amid Revenue Growth

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...

3d

Tradepulse Power Inflow Alert: Eli Lilly And Company Climbs 15 Points

ELI LILLY Inc. LLY today experienced a Power Inflow, a significant event for those who follow where smart money goes and ...

Hosted on MSN6d

BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rises On Upsized IPO

BioAge Labs stock rose Thursday on the company's upsized IPO — reflecting enthusiasm for its approach to obesity treatments.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results